These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20054028)

  • 1. Anaemia, microcytosis and sirolimus--is iron the missing link?
    Sofroniadou S; Kassimatis T; Goldsmith D
    Nephrol Dial Transplant; 2010 May; 25(5):1667-75. PubMed ID: 20054028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR inhibition and erythropoiesis: microcytosis or anaemia?
    Diekmann F; Rovira J; Diaz-Ricart M; Arellano EM; Vodenik B; Jou JM; Vives-Corrons JL; Escolar G; Campistol JM
    Nephrol Dial Transplant; 2012 Feb; 27(2):537-41. PubMed ID: 21785038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.
    Moreno A; Bárcena R; García-Gonzalez M; García-Hoz F; Quereda C; Casado JL; Pérez-Elías MJ; Fortún J; Nuño J; Arranz I; Moreno S
    Transplant Proc; 2008 Dec; 40(10):3810-2. PubMed ID: 19100499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
    Friend P; Russ G; Oberbauer R; Murgia MG; Tufveson G; Chapman J; Blancho G; Mota A; Grandaliano G; Campistol JM; Brault Y; Burke JT;
    Transpl Int; 2007 Sep; 20(9):754-60. PubMed ID: 17565578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium.
    Augustine JJ; Rodriguez V; Padiyar A; Bodziak KA; Schulak JA; Hricik DE
    Transplantation; 2008 Aug; 86(4):548-53. PubMed ID: 18724224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus interferes with iron homeostasis in renal transplant recipients.
    Maiorano A; Stallone G; Schena A; Infante B; Pontrelli P; Schena FP; Grandaliano G
    Transplantation; 2006 Oct; 82(7):908-12. PubMed ID: 17038905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked erythrocyte microcytosis under primary immunosuppression with sirolimus.
    Kim MJ; Mayr M; Pechula M; Steiger J; Dickenmann M
    Transpl Int; 2006 Jan; 19(1):12-8. PubMed ID: 16359372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
    Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM; Sahin S; Kantarci G; Ergin H
    Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.
    Morard I; Dumortier J; Spahr L; Hadengue A; Majno P; Morel P; Mentha G; Giostra E
    Liver Transpl; 2007 May; 13(5):658-64. PubMed ID: 17457887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcytic anaemia in juvenile chronic arthritis.
    Harvey AR; Pippard MJ; Ansell BM
    Scand J Rheumatol; 1987; 16(1):53-9. PubMed ID: 3589590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients.
    Sánchez Fructuoso A; Calvo N; Moreno MA; Giorgi M; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2242-4. PubMed ID: 17889151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early sirolimus therapy in renal transplant recipients at high risk: is it justified?
    Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Al-Waheeb S; Hasaneen H; Awadain WH; Nawas KM; El-Sayed A; Said T; Nair MP; Nampoory MR
    Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell indices and therapeutic trial of iron in diagnostic work-up for anemic Thai females.
    Nuchprayoon I; Sukthawee B; Nuchprayoon T
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S160-9. PubMed ID: 12929984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
    Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
    Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.
    Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED
    Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.